BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9914731)

  • 1. [Thrombophilia, anticoagulant therapy and pregnancy].
    Boda Z; László P; Pfliegler G; Tornai I; Rejtö L; Schlammadinger A
    Orv Hetil; 1998 Dec; 139(52):3113-6. PubMed ID: 9914731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulant therapy and thromboprophylaxis in patients with thrombophilia.
    Weintraub AY; Sheiner E
    Arch Gynecol Obstet; 2007 Dec; 276(6):567-71. PubMed ID: 17828548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin.
    Ghosh K; Shetty S; Vora S; Salvi V
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):174-9. PubMed ID: 18160603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited thrombophilia: treatment during pregnancy.
    De Carolis S; Ferrazzani S; De Stefano V; Garofalo S; Fatigante G; Rossi E; Leone G; Caruso A
    Fetal Diagn Ther; 2006; 21(3):281-6. PubMed ID: 16601339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy.
    James AH; Brancazio LR; Ortel TL
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):187-97. PubMed ID: 16166990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Low-molecular-weight heparin in the prevention of thromboembolism in pregnant thrombophilic patients].
    Boda Z; László P; Rejtö L; Tornai I; Pfliegler G; Rák K
    Orv Hetil; 1996 Jan; 137(4):183-5. PubMed ID: 8721833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG
    Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis and treatment of thrombophilia in pregnancy.
    Gris JC; Lissalde-Lavigne G; Quéré I; Dauzat M; Marès P
    Curr Opin Hematol; 2006 Sep; 13(5):376-81. PubMed ID: 16888444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
    Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
    Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
    de Jong PG; Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD004734. PubMed ID: 24995856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preventing adverse obstetric outcome in women with thrombophilia].
    Verspyck E
    Ann Med Interne (Paris); 2003; 154(5-6):366-9. PubMed ID: 15027592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombophilia and the obstetric patient.
    Cleary-Goldman J; Bettes B; Robinson JN; Norwitz E; Schulkin J
    Obstet Gynecol; 2007 Sep; 110(3):669-74. PubMed ID: 17766616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of systemic hemostatic parameters by enoxaparin during gestation in women with thrombophilia and pregnancy loss.
    Sarig G; Blumenfeld Z; Leiba R; Lanir N; Brenner B
    Thromb Haemost; 2005 Nov; 94(5):980-5. PubMed ID: 16363240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of low-molecular-weight heparin from the first trimester of pregnancy: a retrospective study of 111 consecutive pregnancies.
    Deruelle P; Denervaud M; Hachulla E; Ducloy-Bouthors AS; Valat AS; Puech F; Trillot N; Hatron PY; Subtil D
    Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):73-8. PubMed ID: 16242833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the role of low-molecular-weight heparins in pregnancy.
    Greer IA
    Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():25-31. PubMed ID: 12232820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of thrombosis in pregnancy: role of low-molecular-weight heparin.
    Kher A; Bauersachs R; Nielsen JD
    Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of low-molecular-weight heparins in pregnancy--how safe are they?
    Deruelle P; Coulon C
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):573-7. PubMed ID: 18007136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factor V Leiden mutation. Successful outcome of a pregnancy after heparin therapy].
    Mazzarella CR; Del Bianco A; Pietropaolo F
    Minerva Ginecol; 2003 Feb; 55(1):81-5. PubMed ID: 12598848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women.
    Folkeringa N; Brouwer JL; Korteweg FJ; Veeger NJ; Erwich JJ; Holm JP; van der Meer J
    Br J Haematol; 2007 Feb; 136(4):656-61. PubMed ID: 17223916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombophilia and anticoagulation in pregnancy: indications, risks and management.
    Montavon C; Hoesli I; Holzgreve W; Tsakiris DA
    J Matern Fetal Neonatal Med; 2008 Oct; 21(10):685-96. PubMed ID: 19012185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.